{
  "trial_id": "NCT02190695",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "AML, relapsed or refractory to standard therapy or elderly patients with AML (age 65 or over)",
      "label": "met"
    },
    {
      "criterion": "Patients who have AML and are younger than age 65 but considered unfit for conventional chemotherapy",
      "label": "met"
    },
    {
      "criterion": "Patients with de novo or treated MDS or CMML INT-1 or above",
      "label": "met"
    },
    {
      "criterion": "Patients may have had prior exposure to azacitidine but no more than one cycle of decitabine",
      "label": "unknown"
    },
    {
      "criterion": "Patients must have been off chemotherapy for 2 weeks prior to entering this study and have recovered from the toxicities of that therapy; A caveat to this is in the case of rapidly progressive disease.",
      "label": "met"
    },
    {
      "criterion": "Hydroxyurea is permitted for control of elevated WBC prior to treatment and can be continued for the first 4 weeks of therapy",
      "label": "unknown"
    },
    {
      "criterion": "ESAs, GCSF or other growth factors are permitted on therapy.",
      "label": "met"
    },
    {
      "criterion": "Performance 0-2 (ECOG)",
      "label": "met"
    },
    {
      "criterion": "Adequate cardiac functions assessed by 2D ECHO (NYHA cardiac III-IV excluded).",
      "label": "unknown"
    },
    {
      "criterion": "Pre-treatment EKG",
      "label": "unknown"
    },
    {
      "criterion": "Adequate end organ function with creatinine </= 2mg/dL and total bilirubin </= 2mg/dL, AST and ALT </= or = 2.5 X institutional ULN.",
      "label": "met"
    },
    {
      "criterion": "Absence of significant intercurrent illness such as uncontrolled heart failure, unstable angina, cardiac arrhythmia and psychiatric illness which precludes the giving of informed consent.",
      "label": "unknown"
    },
    {
      "criterion": "Signed informed consent",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Nursing and pregnant females. Patients of childbearing potential should practice effective methods of contraception.",
      "label": "triggers"
    },
    {
      "criterion": "Current uncontrolled infections.",
      "label": "triggers"
    },
    {
      "criterion": "Uncontrolled intercurrent illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, or psychiatric illness/social situations that would limit compliance with study requirements.",
      "label": "triggers"
    },
    {
      "criterion": "Chronic kidney disease > stage 3.",
      "label": "unknown"
    },
    {
      "criterion": "HIV infection.",
      "label": "triggers"
    }
  ],
  "notes": "The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer.",
  "_meta": {
    "topic_id": "31",
    "trial_id": "NCT02190695",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}